Navigation Links
Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
Date:8/21/2008

LAKE FOREST, Ill., Aug. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced new national agreements with Premier Purchasing Partners. The multi-year contracts will provide Premier's 2,000 member hospitals with access to special pricing and terms pre-negotiated by Premier for Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals, drug-delivery and gravity administration sets. The five-year Premier agreements will be effective February 1, 2009.

"Premier shares our commitment to improving patient and caregiver safety, while reducing the high costs of healthcare," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "Hospira products and services are well positioned to deliver positive results in these critical areas for the Premier membership. We look forward to collaborating with Premier's member healthcare institutions to provide innovative solutions and drive results."

The new agreements include Hospira's general-purpose medication management technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software; and pain management pumps, such as LifeCare PCA(R) with Hospira MedNet and GemStar(R) ambulatory devices. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. Also covered within the agreement is access to contracts for Hospira's I.V. solutions and associated equipment portfolio, including the company's environmentally preferable VisIV(R) container. This represents the first opportunity for Hospira to offer these full product lines to Premier member healthcare institutions on contract.

About Premier Inc., 2006 Malcolm Baldrige National Quality Award recipient

Serving more than 2,000 U.S. hospitals and 53,000-plus other healthcare sites, the Premier healthcare alliance and its members are transforming healthcare together. Owned by not-for-profit hospitals, Premier operates one of the leading healthcare purchasing networks and the nation's most comprehensive repository of hospital clinical and financial information. A subsidiary operates one of the nation's largest policy-holder owned, hospital professional liability risk-retention groups. A world leader in helping healthcare providers deliver dramatic improvements in care, Premier is working with the United Kingdom's National Health Service North West and the Centers for Medicare & Medicaid Services to improve hospital performance. Headquartered in San Diego, Premier has offices in Charlotte, N.C., Philadelphia and Washington. For more information, visit http://www.premierinc.com.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira Reports Second-Quarter 2008 Results
2. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
3. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
4. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
5. Hospira Acquires Sculptor
6. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
7. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira Launches Generic Irinotecan Injection
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... San Fernando Valley, CA (PRWEB) , ... December 07, 2016 , ... ... Sculptra can be used in several ways to restore a more youthful appearance to ... doctors , now offer Sculptra, along with a variety of other treatments, to rejuvenate ...
(Date:12/7/2016)... ... 2016 , ... ODU, a worldwide leader in designing ... advanced highly customizable contact technology solutions. , ODU Single Contact Technology portfolio includes: ... for a wide range of applications that require customization from industries like emobility, ...
(Date:12/7/2016)... ... 2016 , ... AlignLife clinics nationwide are giving back to their communities by ... receive bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread ... world. , In exchange for generous donations, customers will receive a gift in return. ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John ... by donating a portion of proceeds to two local organizations: North Chicago Animal Control ... & Friends is a team of authorized and trained volunteers who support rescued ...
(Date:12/7/2016)... ... 2016 , ... "ProBrand Flip allows FCPX editors to create unique logo reveals ... of Pixel Film Studios. , ProBrand Flip includes 30 flip book reveal animations. Easily ... from a variety of flip book animations. In Addition, users can modify each preset ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- Lannett Company, Inc. (NYSE: LCI ) today announced that ... for Success Healthcare Conference on December 14, 2016 at 9:20 a.m. ... City . In addition, the company will host ... th Annual Boston Healthcare Conference taking place on December 13, ... ...
(Date:12/6/2016)... Mass. , Dec. 6, 2016  Alopexx Oncology, ... DI-Leu16-IL2, a recombinant antibody fusion protein (immunocytokine) composed of ... recognizes the same target on B cells as Rituxan ... cytokine components but is also involved in tumor targeting, ... anti-cancer vaccine effect. The results of the study (abstract ...
(Date:12/6/2016)... , Dec. 6, 2016 Diabetes & Obesity ... diabetes and obesity disease cluster is currently dominated by ... type 2 diabetes mellitus (T2DM), and the majority of ... of products, is attributable to these indications. While products ... market presence, there are a large number of these ...
Breaking Medicine Technology: